峯孝志 (Takashi Mine) - マイポータル

基本情報

所属: 長崎みなとメディカルセンター臨床腫瘍科主任診療部長
: (兼任)がんワクチンセンター客員准教授
: 長崎大学大学院医歯薬学総合研究科連携講座教授

研究者番号: 00268905
J-GLOBAL ID: 200901057760142166
researchmap会員ID: 1000366251

研究キーワード

研究分野

学歴

- 1992年

久留米大学
久留米大学医学部医学科

受賞

2001年

癌免疫外科研究会奨励賞

論文

Management of Peripheral Neuropathy Induced by Nab-Paclitaxel Treatment for Breast Cancer

Tsuyoshi Ohno, Takashi Mine, Hiroki Yoshioka, Mikiko Kosaka, Sadayuki Matsuda, Maiko De Kerckhove, Charles De Kerckhove, Junji Irie, Keiji Inoue, Masashi Haraguchi …

ANTICANCER RESEARCH 34(8) 4213-4216 2014年8月査読有り
Humoral immune responses to CTL epitope peptides from tumor-associated antigens are widely detectable in humans: A new biomarker for overall survival of patients with malignant diseases

Satoko Matsueda, Nobukazu Komatsu, Kenichi Kusumoto, Shintaro Koga, Akira Yamada, Ryoko Kuromatsu, Shingo Yamada, Ritsuko Seki, Shigeru Yutani, Shigeki Shichijo …

DEVELOPMENTAL AND COMPARATIVE IMMUNOLOGY 41(1) 68-76 2013年9月査読有り
A phase II study of a personalized peptide vaccination for chemotherapy-resistant advanced pancreatic cancer patients

Shigeru Yutani, Nobukazu Komatsu, Munehiro Yoshitomi, Satoko Matsueda, Koji Yonemoto, Takashi Mine, Masanori Noguchi, Yuki Ishihara, Akira Yamada, Kyogo Itoh …

ONCOLOGY REPORTS 30(3) 1094-1100 2013年9月査読有り
Personalized peptide vaccination in patients with refractory non-small cell lung cancer

Koichi Yoshiyama, Yasuhiro Terazaki, Satoko Matsueda, Shigeki Shichijo, Masanori Noguchi, Akira Yamada, Takashi Mine, Tetsuya Ioji, Kyogo Itoh, Kazuo Shirouzu …

INTERNATIONAL JOURNAL OF ONCOLOGY 40(5) 1492-1500 2012年5月査読有り
Immunological evaluation of personalized peptide vaccination in refractory small cell lung cancer

Yasuhiro Terazaki, Koichi Yoshiyama, Satoko Matsueda, Noriko Watanabe, Akihiko Kawahara, Yoshiki Naito, Shigetaka Suekane, Nobukazu Komatsu, Tetsuya Ioji, Akira Yamada …

CANCER SCIENCE 103(4) 638-644 2012年4月査読有り
[Current status and prospects of cancer vaccine therapy].

Mine T, Terazaki Y, Itoh K

Nihon rinsho. Japanese journal of clinical medicine 69(9) 1651-1656 2011年9月査読有り
Characteristics of severe adverse events after peptide vaccination for advanced cancer patients: Analysis of 500 cases

Kazumi Yoshida, Masanor Noguchi, Takashi Mine, Nobukazu Komatsu, Shigeru Yutani, Takato Ueno, Hiroaki Yanagimoto, Kouichirou Kawano, Kyogo Itoh, Akira Yamada

ONCOLOGY REPORTS 25(1) 57-62 2011年1月査読有り
Phase I clinical study of a personalized peptide vaccination available for six different human leukocyte antigen (HLA-A2,-A3,-A11,-A24,-A31 and-A33)-positive patients with advanced cancer

Akira Yamada, Masanori Noguchi, Nobukazu Komatsu, Shigetaka Suekane, Shigeru Yutani, Fukuko Moriya, Takashi Mine, Kosuke Momozono, Koichiro Kawano, Kyogo Itoh

EXPERIMENTAL AND THERAPEUTIC MEDICINE 2(1) 109-117 2011年1月査読有り
Assessment of immunological biomarkers in patients with advanced cancer treated by personalized peptide vaccination.

Masanori Noguchi, Takashi Mine, Nobukazu Komatsu, Shigetaka Suekane, Fukuko Moriya, Kei Matsuoka, Shigeru Yutani, Shigeki Shichijo, Akira Yamada, Uhi Toh …

Cancer biology & therapy 10(12) 1266-79 2010年12月15日査読有り
Short GC-rich RNA similar to miR 1909 and 1915 folds in silico with the 5 '-UTR and ORF of Notch and responders: Potential for the elimination of cancer stem cells

Yufeng Li, Takashi Mine, Constantin G. Ioannides

ONCOLOGY REPORTS 24(6) 1443-1453 2010年12月査読有り
A phase II study of personalized peptide vaccination combined with gemcitabine for non-resectable pancreatic cancer patients

Hiroaki Yanagimoto, Hisanori Shiomi, Sohei Satoi, Takashi Mine, Hideyoshi Toyokawa, Tomohisa Yamamoto, Tohru Tani, Akira Yamada, A-Hon Kwon, Nobukazu Komatsu …

ONCOLOGY REPORTS 24(3) 795-801 2010年9月査読有り
Created Gli-1 duplex short-RNA (i-Gli-RNA) eliminates CD44(Hi) progenitors of taxol-resistant ovarian cancer cells

Takashi Mine, Satoko Matsueda, Hui Gao, Yufeng Li, Kwong-Kwok Wong, George E. Peoples, Soldano Ferrone, Constantin G. Ioannides

ONCOLOGY REPORTS 23(6) 1537-1543 2010年6月査読有り
Immunological evaluation of personalized peptide vaccination monotherapy in patients with castration-resistant prostate cancer.

Hirotsugu Uemura, Kiyohide Fujimoto, Takashi Mine, Shigeya Uejima, Marco A de Velasco, Yoshihiko Hirao, Nobukazu Komatsu, Akira Yamada, Kyogo Itoh

Cancer science 101(3) 601-8 2010年3月査読有り
[A phase I study of combination-therapy using personalized peptide vaccine and UFT/UZEL for advanced or recurrent colorectal cancer].

Hattori T, Okuno K, Yoshida K, Kokubu T, Mine T, Yamada R, Itoh K, Shiozaki H

Gan to kagaku ryoho. Cancer & chemotherapy 33(12) 1745-1747 2006年11月査読有り
[Acquired tumor "robustness" in the case of prostate cancer].

Homma S, Noguchi M, Sato Y, Maeda Y, Shomura H, Komohara Y, Mine T, Harada M, Yamada A, Todo S …

Gan to kagaku ryoho. Cancer & chemotherapy 33(12) 1748-1750 2006年11月査読有り
[CTL precursor-oriented peptide vaccine therapy for malignant glioma].

Yajima N, Yamanaka R, Tanaka R, Shigemori M, Mine T, Itoh K

Nihon rinsho. Japanese journal of clinical medicine 63 Suppl 9 582-587 2005年9月査読有り
Identification of epidermal growth factor receptor-derived peptides recognised by both cellular and humoral immune responses in HLA-A24(+) non-small cell lung cancer patients

H Shomura, S Shichijo, N Komatsu, S Matsueda, T Mine, T Rikimaru, Y Sato, S Todo, K Itoh

EUROPEAN JOURNAL OF CANCER 40(11) 1776-1786 2004年7月査読有り
[Autologous tumor specific immunotherapy of refractory cancers with ex vivo-generated T cells stimulated by autologous tumor cell].

Toh U, Yamana H, Kido K, Mine T, Fujii T, Horiuchi H, Sasatomi T, Ishibashi N, Yutani S, Fujita H …

Gan to kagaku ryoho. Cancer & chemotherapy 30(11) 1566-1570 2003年10月査読有り
Peptide vaccination for patients with melanoma and other types of cancer based on pre-existing peptide-specific ctotoxic T-lymphocyte precursors in the periphery.

Tanaka S, Harada M, Mine T, Noguchi M, Gohara R, Azuma K, Tamura M, Yamada A, Morinaga A, Nishikori M …

Journal of immunotherapy (Hagerstown, Md. : 1997) 26(4) 357-366 2003年7月査読有り
Optimal lymphadenectomy for squamous cell carcinoma in the thoracic esophagus: Comparing the short- and long-term outcome among the four types of lymphadenectomy

H Fujita, S Sueyoshi, T Tanaka, T Fujii, U Toh, T Mine, H Sasahara, T Sudo, S Matono, H Yamana …

WORLD JOURNAL OF SURGERY 27(5) 571-579 2003年5月査読有り

もっとみる

MISC

Immunological evaluation of personalized peptide vaccination in combination with UFT and UZEL for metastatic colorectal carcinoma patients

Takashi Hattori, Takashi Mine, Nobukazu Komatsu, Akira Yamada, Kyogo Itoh, Hitoshi Shiozaki, Kiyotaka Okuno

CANCER IMMUNOLOGY IMMUNOTHERAPY 58(11) 1845-1854 2009年11月
Breast cancer cells expressing stem cell markers CD44(+) CD24(lo) are eliminated by Numb-1 peptide-activated T cells

Takashi Mine, Satoko Matsueda, Yufeng Li, Hiroshi Tokumitsu, Hui Gao, Cristopher Danes, Kwong-Kwok Wong, Xinhui Wang, Soldano Ferrone, Constantin G. Ioannides

CANCER IMMUNOLOGY IMMUNOTHERAPY 58(8) 1185-1194 2009年8月
Recent Advances in Cancer Vaccines: An Overview

Kyogo Itoh, Akira Yamada, Takashi Mine, Masanori Noguchi

JAPANESE JOURNAL OF CLINICAL ONCOLOGY 39(2) 73-80 2009年2月
Synthetic microRNA targeting glioma-associated antigen-1 protein

Tsuda N, Mine T, Ioannides CG, Chang DZ

Methods Mol Biol 487 435-49 2009年
Working hypothesis: Elimination of cancer stem cells in solid tumors by immuno-gene therapy using cancer vaccines and created-inhibitory RNA

Takashi Mine, Soldano Ferrone, Georges Vlastos, George E. Peoples, Constantin G. Ioannides

Current Cancer Therapy Reviews 5(3) 217-226 2009年
Immunological evaluation of personalized peptide vaccination in combination with a 5-fluorouracil derivative (TS-1) for advanced gastric or colorectal carcinoma patients

Yuji Sato, Toshiyoshi Fujiwara, Takashi Mine, Hiroki Shomura, Shigenori Homma, Yoshiaki Maeda, Naoyuki Tokunaga, Yoshihiro Ikeda, Yuki Ishihara, Akira Yamada …

CANCER SCIENCE 98(7) 1113-1119 2007年7月
Immunological evaluation of personalized peptide vaccination with gemcitabine for pancreatic cancer

Hiroaki Yanagimoto, Takashi Mine, Koutaro Yamamoto, Sohei Satoi, Naoyoshi Terakawa, Kanji Takahashi, Kimika Nakahara, Shigenori Honma, Masahiro Tanaka, Junko Mizoguchi …

CANCER SCIENCE 98(4) 605-611 2007年4月
Combination therapy of personalized peptide vaccination and low-dose estramustine phosphate for metastatic hormone refractory prostate cancer patients: an analysis of prognostic factors in the treatment.

Noguchi M, Mine T, Yamada A, Obata Y, Yoshida K, Mizoguchi J, Harada M, Suekane S, Itoh K, Matsuoka K

16(7) 341-9 2007年
Increased levels of IgG antibodies against peptides of the prostate stem cell antigen in the plasma of pancreatic cancer patients.

Tanaka M, Komatsu N, Terakawa N, Yanagimoto Y, Oka M, Sasada T, Mine T, Gouhara S, Shichijo S, Okuda S …

Oncol Rep 18(1) 161-6 2007年
Taxol increases the amount and T cell activating ability of self-immune stimulatory multimolecular complexes found in ovarian cancer cells.

Tsuda N, Chang DZ, Mine T, Efferson C, Garcia-Sastre A, Wang X, Ferrone S, Ioannides CG

Cancer Res. 67(17) 8378-87 2007年
Antitumor effects of systemic and local immunization with a CTL-directed peptide in combination with a local injection of OK-432

T Ono, M Harada, A Yamada, M Tanaka, Y Takao, Y Tanaka, T Mine, K Sakamoto, T Nakashima, K Itoh

CLINICAL CANCER RESEARCH 12(4) 1325-1332 2006年2月
Immunologic evaluation of personalized peptide vaccination for patients with advanced malignant glioma

N Yajima, R Yamanaka, T Mine, N Tsuchiya, J Homma, M Sano, T Kuramoto, Y Obata, N Komatsu, Y Arima …

CLINICAL CANCER RESEARCH 11(16) 5900-5911 2005年8月
Immunological evaluation of personalized peptide vaccination for patients with pancreatic cancer

K Yamamoto, T Mine, K Katagiri, N Suzuki, T Kawaoka, T Ueno, S Matsueda, A Yamada, K Itoh, H Yamana …

ONCOLOGY REPORTS 13(5) 875-883 2005年5月
Immunological evaluation of individualized peptide vaccination with a low dose of estramustine for HLA-A24(+) HRPC patients

M Noguchi, K Itoh, A Yao, T Mine, A Yamada, Y Obata, M Furuta, M Harada, S Suekane, K Matsuoka

PROSTATE 63(1) 1-12 2005年4月
Identification of epidermal growth factor receptor-derived peptides recognised by both cellular and humoral immune responses in HLA-A24(+) non-small cell lung cancer patients

H Shomura, S Shichijo, N Komatsu, S Matsueda, T Mine, T Rikimaru, Y Sato, S Todo, K Itoh

EUROPEAN JOURNAL OF CANCER 40(11) 1776-1786 2004年7月
Humoral responses to peptides correlate with overall survival in advanced cancer patients vaccinated with peptides based on pre-existing, peptide-specific cellular responses

T Mine, Y Sato, M Noguchi, T Sasatomi, R Gouhara, N Tsuda, S Tanaka, H Shomura, K Katagiri, T Rikimaru …

CLINICAL CANCER RESEARCH 10(3) 929-937 2004年2月
峯孝志,由谷茂,伊東恭悟,山名秀明: 患者オリエンテッド癌免疫療法.Medical Science Digest, 30(4): 15-19.

2004年
Immunological evaluation of peptide vaccination for patients with gastric cancer based on pre-existing cellular response to peptide

Y Sato, H Shomura, Y Maeda, T Mine, Y Une, Y Akasaka, M Kondo, S Takahashi, T Shinohara, K Katagiri …

CANCER SCIENCE 94(9) 802-808 2003年9月
Peptide vaccination for patients with melanoma and other types of cancer based on pre-existing peptide-specific cytotoxic T-lymphocyte precursors in the periphery

S Tanaka, M Harada, T Mine, M Noguchi, R Gohara, K Azuma, M Tamura, A Yamada, A Morinaga, M Nishikori …

JOURNAL OF IMMUNOTHERAPY 26(4) 357-366 2003年7月
Immunological evaluation of CTL precursor-oriented vaccines for advanced lung cancer patients

T Mine, R Gouhara, N Hida, N Imai, K Azuma, T Rikimaru, K Katagiri, M Nishikori, A Sukehiro, M Nakagawa …

CANCER SCIENCE 94(6) 548-556 2003年6月

もっとみる

峯孝志

基本情報

研究キーワード

研究分野

学歴

受賞

論文

MISC

所属学協会

共同研究・競争的資金等の研究課題

メニュー